Our previous studies showed that increased expression of the co-inhibitory receptor PD-1 in CD4+ TE/M cells from anti-IL-7Rα-treated NOD mice contributed to protection from type 1 diabetes [4]. Here, IL7R is linked to type 1 diabetes mellitus.